(NU/1433-47) Kargenera: The Provision of Business Consultancy to Assist Commercialisation of University Research
Newcastle University · Awarded
- Buyer
- Newcastle University
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Professional Services
- Reference
- FaT-ocds-h6vhtk-03a331
- Published
- 2023-02-06
- Deadline
- 2026-04-23
Tender summary
The University of Southampton have developed a unique DNA based therapeutic to activate NK cells against cancer. The therapeutic is delivered intramuscularly in combination with DNA encoding the potent immune stimulating cytokine IL-15. The objective is for an Executive to jointly work with the team to bring the opportunity towards and ultimately achieve launch of a new spinout company.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access